Combining the freedom of true independence with the platform and support of a full service brokerage firm.
NeoStem, Inc. AMEX: NBS The undersigned served as exclusive financial advisor to NeoStem, Inc.
The Client Together with its subsidiaries, operates a network of commercial autologous adult stem cell banks in the metropolitan areas of the United States. It provides adult stem cell processing, collection, cryopreservation, and banking services. The Client was acquiring a manufacturer of pharmaceutical products in the People’s Republic of China.
The Mandate National was asked by the Company’s Board of Directors to examine a contemplated transaction and opine as to the fairness, from a financial perspective to the Company’s non-affiliated shareholders, as to the contemplated consideration to paid for the assets, which include the forfeiture of certain securities as well as other equity.
The Solution Following the delivery of the Fairness Opinion to NBS, the Company was able to act decisively and thus move forward with the transaction acting in the best interest of their non-affiliated shareholders.